Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease

American Journal of Cardiology

Volumn 80, Issue 7, 1997, Pages 825-830

  Mosca, Lori ^a,b   Rubenfire, Melvyn ^a,b   Tarshis, Tom ^a,b   Tsai, Alan ^a,b   Pearson, Thomas ^a,b  

^a Preventive Cardiology Program   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; EXERCISE; FAMILY HISTORY; FEMALE; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL; CORONARY DISEASE; FEMALE; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RISK FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIGLYCERIDES;

EID: 0030665071     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00530-4     Document Type: Article

References (29)

1. Jayakumari N, Ambikakumari V, Balakrishnan KG, Subramonia Iyer K. Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis. 94:1992;183-190.
2. Duthie GG, Beattie JA, Arther JR, Franklin M, Morrice PC, Jams WP. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris. Nutrition. 10:1994;313-316.
3. Miwa K, Miyagi U, Fujita M. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol. 26:1995;632-638.
4. Blackman BC, White P, Tsou W, Finkel D. Peroxidation of plasma and platelet lipids in chronic cigarette smokers and insulin-dependent diabetics. Ann NY Acad Sci. 435:1984;385-387.
5. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis. 79:1989;245-252.
6. Weiland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res. 24:1983;904-909.
7. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;627-630.
8. Placer ZA. Lipid peroxidation in vivo. Nutrition. Proceedings of the Eighth International Congress. 1970;100-105 Excerpta Medica, Amsterdam.
9. Naito C, Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. Ann NY Acad Sci. 676:1993;27-45.
10. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms. 6:1989;67-75.
11. Allain CA, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
12. McGowan MW, Artiss JD, Strandergh DR, Azk B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 29:1983;538-542.
13. 2. Clin Chem. 29:1983;2026-2030.
14. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 40:1978;497-504.
15. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exercise. 12:1980;175-182.
16. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med. 320:1989;915-924.
17. Maynard C, Litwin PE, Maartis JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Arch Intern Med. 152:1992;972-976.
18. Subbiah MTR, Kessel B, Agrawal M, Raghunandan R, Abplanalp W, Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab. 77:1993;1095-1097.
19. Chow CK, Thacker RR, Changchit C, Bridges RB, Rehm SR, Humble J, Turbek J. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr. 5:1986;305-312.
20. Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GTL. Cigarette smoking and plasma high density lipoprotein cholesterol: the Lipid Research Clinics Program Prevalence Study. Circulation. 62:(4):1980;70-76.
21. Rexrode K, Manson J, Hennekens C. Obesity and cardiovascular disease. Curr Opin Cardiol. 11:1996;490-495.
22. Croft KD, Dimmitt SB, Moulton C, Beilin LJ. Low density lipoprotein composition and oxidizability in coronary disease - apparent favourable effect of beta blockers. Atherosclerosis. 97:1992;123-130.
23. Robertson JD, Maugham RJ, Duthie GG, Morrice PC. Increased blood antioxidant systems of runners in response to training load. Clin Sci. 80:1991;611-618.
24. Gaziano JM, Buring JE, Breslow JL, Goldhabeer SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 329:1993;1829-1834.
25. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am J Cardiol. 71:1993;467-469.
26. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic subsances in red wine. Lancet. 341:1993;454-457.
27. Mosca L, Rubenfire M, Mandel C, Rock R, Tarshis T, Tsai A, Pearson T. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease. J Am Coll Cardiol. 30:1997;392-399.
28. Stephens N, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson M, Brown M. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
29. Chait A. Methods for assessing lipid and lipoprotein oxidation. Cur Opin Lipid. 3:1992;389-394.